These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1381909)
1. Correlation between detection of anti-viral antibody and histopathological disease activity in an epidemic of hepatitis C. Fukuda Y; Nagura H; Takayama T; Imoto M; Shibata M; Kudo T; Morishima T; Miyamura T; Nagai Y Arch Virol; 1992; 126(1-4):171-8. PubMed ID: 1381909 [TBL] [Abstract][Full Text] [Related]
2. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera. Morii K; Shimomura H; Nakagawa H; Hasui T; Tsuji T Acta Med Okayama; 1992 Aug; 46(4):285-93. PubMed ID: 1332424 [TBL] [Abstract][Full Text] [Related]
3. High rate of mixed genotypes of hepatitis C virus in patients of an epidemic area in Japan. Yamada M; Fukuda Y; Imoto M; Koyama Y; Hayakawa T; Takayama T; Nagura H J Gastroenterol Hepatol; 1994; 9(6):620-3. PubMed ID: 7532450 [TBL] [Abstract][Full Text] [Related]
4. Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction. Shieh YS; Shim KS; Lampertico P; Balart LA; Jeffers LJ; Thung SN; Regenstein F; Reddy KR; Farr G; Schiff ER Lab Invest; 1991 Oct; 65(4):408-11. PubMed ID: 1656140 [TBL] [Abstract][Full Text] [Related]
5. HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease. Yuki N; Hayashi N; Hagiwara H; Takehara T; Kasahara A; Fusamoto H; Manabe S; Takamizawa A; Kamada T; Okayama H Dig Dis Sci; 1992 Oct; 37(10):1483-8. PubMed ID: 1327684 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643 [TBL] [Abstract][Full Text] [Related]
8. [Seroepidemiological study on hepatitis C virus infection in an endemic area of hepatitis C virus]. Goto T; Misumi J; Shimaoka A; Aoki K; Yasui T; Kudo M Kansenshogaku Zasshi; 1993 Jul; 67(7):635-41. PubMed ID: 7689623 [TBL] [Abstract][Full Text] [Related]
9. [Investigation of anti-hepatitis C virus in the sera of different populations of Beijing]. Zhonghua Yi Xue Za Zhi; 1992 Jan; 72(1):18-20, 62-3. PubMed ID: 1374286 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease]. Sakashita H Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128 [TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. Piazza M; Borgia G; Picciotto L; Nappa S; Cicciarello S; Orlando R J Med Virol; 1995 Jan; 45(1):40-2. PubMed ID: 7536229 [TBL] [Abstract][Full Text] [Related]
12. Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus. Petrelli E; Manzin A; Paolucci S; Cioppi A; Brugia M; Muretto P; Clementi M J Clin Pathol; 1994 Feb; 47(2):148-51. PubMed ID: 7510725 [TBL] [Abstract][Full Text] [Related]
13. [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein]. Hayashi N; Yuki N; Kasahara A; Fusamoto H; Kamada T Nihon Rinsho; 1993 Feb; 51(2):329-33. PubMed ID: 7681883 [TBL] [Abstract][Full Text] [Related]
14. A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes. Kuboki M; Shinzawa H; Shao L; Ishibashi M; Yoshii E; Suzuki K; Saito K; Saito T; Togashi H; Takahashi T; Yasumura S; Fukao A Liver; 1999 Apr; 19(2):88-96. PubMed ID: 10220737 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma. Watanabe Y; Harada S; Saito I; Miyamura T Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205 [TBL] [Abstract][Full Text] [Related]
16. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis. Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269 [TBL] [Abstract][Full Text] [Related]
18. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Prieto M; Olaso V; Verdú C; Córdoba J; Gisbert C; Rayón M; Carrasco D; Berenguer M; Higón MD; Berenguer J Hepatology; 1995 Aug; 22(2):413-7. PubMed ID: 7635408 [TBL] [Abstract][Full Text] [Related]
19. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C. Yang PM; Hwang LH; Lai MY; Huang WL; Chu YD; Chi WK; Chiang BL; Kao JH; Chen PJ; Chen DS Clin Exp Immunol; 1995 Aug; 101(2):272-7. PubMed ID: 7544249 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Yano M; Yatsuhashi H; Inoue O; Inokuchi K; Koga M Gut; 1993; 34(2 Suppl):S13-6. PubMed ID: 7686112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]